Carl Runde

Carl Runde is an accomplished financial executive currently serving as Chief Financial Officer and Company Secretary at Atmo Biosciences since February 2022, while also contributing as a Casual Academic at The University of Sydney Business School. Previously, Carl held the position of Chief Financial Officer at Osteopore Limited and has extensive experience from ResMed, where responsibilities included Vice President roles in Corporate Systems and FP&A as well as Global Research & Development. Additional academic contributions include being an Adjunct Lecturer at Macquarie Graduate School of Management. Carl's earlier roles encompass financial management positions at MAP Medizin-Technologie GmbH, Käfer, and Hilton International. Academic credentials include a Doctor of Philosophy from the University of Sydney, an MBA from Macquarie Business School, and dual Bachelor's degrees with Honours from the University of the Witwatersrand in International Relations.